Primary Hyperparathyroidism: Imaging to Pathology
Open Access
- 6 October 2012
- journal article
- review article
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 2 (1) , 59
- https://doi.org/10.4103/2156-7514.102053
Abstract
The aim of this review is to describe the multimodal imaging (ultrasound, magnetic resonance, computed tomography, and nuclear medicine) of primary hyperparathyroidism and its correlation to the pathological findings. In the last decades, imaging science has progressed a great deal. Accurate preoperative localization of the involved glands is essential for surgical success.Keywords
This publication has 68 references indexed in Scilit:
- Preoperative 123I/99mTc-Sestamibi Subtraction SPECT and SPECT/CT in Primary HyperparathyroidismJournal of Nuclear Medicine, 2008
- Preoperative localization of parathyroid lesionsNuklearmedizin-Nuclear Medicine, 2008
- Parathyroid Imaging: Technique and Role in the Preoperative Evaluation of Primary HyperparathyroidismAmerican Journal of Roentgenology, 2007
- Parathyroid CarcinomaAdvances in Anatomic Pathology, 2005
- Differences between 99mTc-sestamibi and 99mTc-tetrofosmin uptake in thyroid and salivary glands: comparison with 99mTc-pertechnetate in 86 subjectsNuclear Medicine Communications, 2003
- Tc-99m Tetrofosmin A New Diagnostic Tracer for Parathyroid ImagingClinical Nuclear Medicine, 1995
- Preoperative Imaging of Abnormal Parathyroid Glands in Patients with Hyperparathyroid Disease Using Combination Tc-99m-Pertechnetate and Tc-99m-Sestamibi Radionuclide ScansAnnals of Surgery, 1994
- Visualization of a Parathyroid Adenoma with Tc-99m MIBI in a Case with Iodine Saturation and Impaired Thallium UptakeClinical Nuclear Medicine, 1993
- Parathyroid imaging by Tc/TI scintigraphyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1990
- 99Tcm sestamibi — a new agent for parathyroid imagingNuclear Medicine Communications, 1989